Not applicableStudy completedNCT07498413What this trial is testingEpidemiology and Treatment of HR+/HER2- Breast Cancer in EnglandWho this might be right forBreast Cancer Novartis Pharmaceuticals 218,677
Testing effectiveness (Phase 2)Ended earlyNCT00780000What this trial is testingClinical Trial of Intravenous Alvespimycin in Patients With Her2 Positive Breast CancerWho this might be right forBreast Cancer Bristol-Myers Squibb 4
Testing effectiveness (Phase 2)Study completedNCT02236000What this trial is testingA Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast CancerWho this might be right forBreast Cancer NSABP Foundation Inc 49
Not applicableStudy completedNCT02625935What this trial is testingProspective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer PatientsWho this might be right forBreast Cancer NanoString Technologies, Inc. 206
Large-scale testing (Phase 3)Not Yet RecruitingNCT04736589What this trial is testingInetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM PathwayWho this might be right forBreast Cancer Peking Union Medical College 270
Testing effectiveness (Phase 2)Ended earlyNCT01290718What this trial is testingHerceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy.Who this might be right forBreast Cancer Hoffmann-La Roche 4
Large-scale testing (Phase 3)Looking for participantsNCT07190443What this trial is testingAdjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)Who this might be right forBreast CancerLocoregional RecurrenceAbemaciclib+1 more Japanese Foundation for Cancer Research 290
Large-scale testing (Phase 3)Study completedNCT02422615What this trial is testingStudy of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.Who this might be right forAdvanced Breast Cancer Novartis Pharmaceuticals 726
Testing effectiveness (Phase 2)Active Not RecruitingNCT02311933What this trial is testingTamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast CancerWho this might be right forRecurrent Breast CarcinomaStage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7+3 more National Cancer Institute (NCI) 81
Testing effectiveness (Phase 2)Ended earlyNCT01534455What this trial is testingEfficacy and Tolerability of Eribulin Plus Lapatinib in Patients With Metastatic Breast Cancer (E-VITA)Who this might be right forMetastatic Breast Cancer GBG Forschungs GmbH 43
Not applicableLooking for participantsNCT04660435What this trial is testingTo Identify Primary Resistance to CDK4/6 Inhibitors in Breast CancerWho this might be right forMetastatic Breast CancerER Positive Breast CancerHER2-negative Breast Cancer Fondazione Sandro Pitigliani 150
Large-scale testing (Phase 3)Active Not RecruitingNCT05038735What this trial is testingStudy to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.Who this might be right forBreast Cancer Novartis Pharmaceuticals 210
Not applicableStudy completedNCT06833268What this trial is testingReal-world Outcomes of Patients With HER2+ Metastatic Breast Cancer After Treatment With Trastuzumab DeruxtecanWho this might be right forHER2-positive Breast Cancer Daiichi Sankyo 228
Testing effectiveness (Phase 2)Looking for participantsNCT05872347What this trial is testingEfficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.Who this might be right forBreast Cancer Brain Metastases Shanghai Pharmaceuticals Holding Co., Ltd 52
Testing effectiveness (Phase 2)UnknownNCT02681562What this trial is testingOlaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer PatientsWho this might be right forBreast CancerTriple Negative Breast Cancer Istituti Ospitalieri di Cremona 45
Large-scale testing (Phase 3)Active Not RecruitingNCT04639986What this trial is testingAsian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)Who this might be right forMetastatic Breast Cancer Gilead Sciences 331
Large-scale testing (Phase 3)Ended earlyNCT04740918What this trial is testingTrastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)Who this might be right forMetastatic Breast Cancer Hoffmann-La Roche 96
Post-approval studies (Phase 4)Looking for participantsNCT05452213What this trial is testingComprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer PatientsWho this might be right forBreast CancerBreast NeoplasmsBreast Neoplasm Female+4 more Institut fuer Frauengesundheit 1,000
Not applicableLooking for participantsNCT06358625What this trial is testingIdentification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast CancerWho this might be right forHER2-positive Breast Cancer Center Eugene Marquis 120
Early research (Phase 1)Looking for participantsNCT06949410What this trial is testingHER2 Vaccine for Locally Advanced Breast CancerWho this might be right forBreast CancerHER2-positive Breast Cancer Pravin T.P Kaumaya 36